Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1395-1404

  Jenson, Hal B ^{a,b,c,d,e,f,g}   McIntosh, Kenneth ^a,b,c,d,e,f   Pitt, Jane ^a,b,c,d,e,f   Husak, Scott ^a,b,c,d,e,f   Tan, Ming ^a,b,c,d,e,f   Bryson, Yvonne ^a,b,c,d,e,f   Easley, Kirk ^a,b,c,d,e,f  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; FEMALE; HEPATOMEGALY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INFANT; INFECTION RISK; INFECTION SENSITIVITY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MULTICENTER STUDY; PRIORITY JOURNAL; SEROCONVERSION; SPLENOMEGALY;

AFRICAN AMERICANS; AGE FACTORS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HISPANIC AMERICANS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; VIRUS SHEDDING;

EID: 0033028521     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314764     Document Type: Article

References (49)

1. 1. Niederman JC, Evans AS. Epstein-Barr virus. In: Evans AS, Kaslow RA, eds. Viral infections of humans: Epidemiology and control. 4th ed. New York: Plenum, 1997:253-83.
2. 2. Wang PS, Evans AS. Prevalence of antibodies to Epstein-Barr virus and cytomegalovirus in sera from a group of children in the People's Republic of China. J Infect Dis 1986;153:150-2.
3. 3. Evans AS, Niederman JC, McCollum RW. Scroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med 1968;279:1121-7.
4. 4. Niederman JC, Evans AS, Subrahmanyan L, McCollum RW. Prevalence, incidence, and persistence of EB virus antibody in young adults. N Engl J Med 1970;282:361-5.
5. 5. Greenspan JS, Greenspan D, Lennette ET, et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 1985;313:1564-71.
6. 6. Sciubba J, Brandsma J, Schwartz M, Barrezueta N. Hairy leukoplakia: an AIDS-associated opportunistic infection. Oral Surg Oral Med Oral Pathol 1989;67:404-10.
7. 7. Kramer MR, Saldana MJ, Ramos M, Pitchenik AE. High titers of Epstein-Barr virus antibodies in adult patients with lymphocytic interstitial pneumonitis associated with AIDS. Respir Med 1992;86:49-52.
8. 8. Andiman WA, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985;2:1390-3.
9. 9. Katz BZ, Berkman AB, Shapiro ED. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992;120:228-32.
10. 10. Barberà JA, Hayashi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992;145:940-6.
11. 11. Travis WD, Fox CH, Devaney KO, et al. Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol 1992;23:524-41.
12. 12. Luginbuhl LM, Orav EJ, McIntosh K, Lipshultz SE. Cardiac morbidity and related mortality in children with HIV infection. JAMA 1993;269: 2869-75.
13. 13. Levine AM. Lymphoma complicating immunodeficiency disorders. Ann Oncol 1994;5(suppl 2):29-35.
14. 14. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 1991;47: 692-6.
15. 15. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995;332:12-8.
16. 16. Jenson HB, Leach CT, McClain KL, et al. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma 1997;27:303-14.
17. 17. Astrin SM, Laurence J. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes. Ann NY Acad Sci 1992; 651:422-32.
18. 18. Henderson EE, Yang JY, Zhang RD, Bealer M. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations. Virology 1991;182:186-98.
19. 19. Tozzi V, Britton S, Ehrnst A, Lenkei R, Strannegárd Ö. Persistent productive HIV infection in EBV-transformed B lymphocytes. J Med Virol 1989;27: 19-24.
20. 20. Pagano JS, Kenney S, Markovitz D, Kamine J. Epstein-Barr virus and interactions with human retroviruses. J Virol Methods 1988;21:229-39.
21. 21. Blumberg RS, Paradis TJ, Crawford D, Byington RE, Hirsch MS, Schooley RT. Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (EBV) transformed B lymphocytes. AIDS Res Hum Retroviruses 1987;3:303-15.
22. 22. Kenney S, Kamine J, Markovitz D, Fenrick R, Pagano J. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci USA 1988;85:1652-6.
23. 2 HIV) infection study: design and methods. J Clin Epidemiol 1996;49: 1285-94.
24. 24. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14: 702-15.
25. 25. Hollinger FB, Bremer JW, Myers LE, Gold JW, McQuay L. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol 1992;30:1787-94.
26. 26. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12):1-10.
27. 27. Griffith BP, Rigsby MO, Garner RB, Gordon MM, Chacko TM. Comparison of the Amplicor HIV-I monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles. J Clin Microbiol 1997;35:3288-91.
28. 28. Lennette ET. Epstein-Barr virus (EBV). In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 7th ed. Washington, DC: American Public Health Association, 1995:299-312.
29. 29. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-7.
30. 30. Jenson HB, Ench Y, Sumaya CV. Epstein-Barr virus. In: Rose NR, de Macario EC, Folds H, Lane HC, Nakamura RM, eds. Manual of clinical laboratory immunology. 5th ed. Washington, DC: American Society for Microbiology Press, 1997:634-43.
31. 2 HIV study: the role of EBV shedding. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:462-70.
32. 32. Tomkinson BE, Maziarz R, Sullivan JL. Characterization of the T cell mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol 1989;143:660-70.
33. 33. Fleisher G, Bologonese R. Epstein-Barr virus infections in pregnancy: a prospective study. J Pediatr 1984;104:374-9.
34. 34. Le CT, Chang RS, Lipson MH. Epstein-Barr virus infections during pregnancy. A prospective study and review of the literature. Am J Dis Child 1983;137:466-8.
35. 35. Hunter K, Stagno S, Capps E, Smith RJ. Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasma gondii. Am J Obstet Gynecol 1983;145: 269-73.
36. 36. Rahman MA, Kingsley LA, Breinig MK, et al. Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men. J Infect Dis 1989;159:472-9.
37. 37. Scott ME, Landay AL, Lint TF, Spear GT. In vivo decrease in the expression of complement receptor 2 on B-cells in HIV infection. AIDS 1993;7:37-41.
38. 38. Nemerow GR, Mullen JJ, Dickson PW, Cooper NR. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. J Virol 1990;64 1348-52.
39. 39. Ferbas J, Rahman MA, Kingsley LA, et al. Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. AIDS 1992;6:1273-8.
40. 40. Lucht E, Biberfeld P, Linde A. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-I infected persons with and without hairy leukoplakia. J Infect 1995;31:189-94.
41. 41. Chang RS, Lewis JP, Reynolds RD, Sullivan MJ, Neuman J. Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med 1978;88: 34-40.
42. 42. Chatterjee SN, Chang RS. A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal homograft recipients. Scand J Infect Dis 1982;14:95-8.
43. 43. Miller G, Niederman JC, Andrews LL. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med 1973;288:229-32.
44. 44. Niederman JC, Miller G, Pearson HA, Pagano JS, Dowaliby JM. Infectious mononucleosis. Epstein-Barr virus shedding in saliva and the oropharynx. N Engl J Med 1976;294:1355-9.
45. 45. Oudejans JJ, Jiwa M, van den Brule AJ, et al. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 1995;147:923-33.
46. + lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. The Military Pediatric HIV Consortium. Clin Infect Dis 1993;17:123-5.
47. 47. The European Collaborative Study, Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1 infected women. Pediatr Infect Dis J 1992;11:1018-26.
48. 48. Quesnel A, Pozzetto B, Touraine F, et al. Antibodies to Epstein-Barr virus and cytomegalovirus in relation to CD4 cell number in human immunodeficiency virus 1 infection. J Med Virol 1992;36:60-4.
49. 49. Rahman MA, Kingsley LA, Atchison RW, et al. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin Microbiol 1991;29:1215-20.